T. Hattori et al. / Tetrahedron 70 (2014) 4790e4798
4797
1
those of the corresponding authentic samples from commercial
sources or those in the literature, see Supplementary data.
22) from benzophenone (182 mg, 1 mmol). H NMR
d
þ
(CDCl
3
) 4.00
(2H, s), 7.23e7.31 (10H, m); MS (EI) m/z (%) 168 (M , 100).
4
.3.8. 3-Phenylpropionic acid benzyl ester (Table 2, entry 23; Table 3,
4
.2. Typical procedure for the palladium-catalyzed hydroge-
5
b
entries 26 and 28). Obtained (240 mg, 100% for Table 2, entry 23;
nation under the flow conditions (Tables 2 and 3)
2
2
d
40 mg, 100% for Table 3, entry 26; 239 mg, 100% for Table 3, entry
1
8) from cinnamic acid benzyl ester (238 mg, 1 mmol). H NMR
A solution of the substrates possessing reducible functional
groups (1 mmol) within the molecule in MeOH (20 mL) was flowed
at 1 mL/min into the catalyst-packed cartridge (10% Pd/C, 10% Pd/
HP20, 0.5% Pd/MS3A, or 0.3% Pd/BN; 30 mm long-cartridge, ca.
(CDCl
3
) 2.63 (2H, t, J¼7.8 Hz), 2.93 (2H, t, J¼7.8 Hz), 5.01 (2H, s),
þ
7.13e7.32 (10H, m); MS (EI) m/z (%) 240 (M , 10), 180 (36), 91 (100).
4
2
.3.9. 3-Phenylpropionic acid (Table 2, entries 24 and
0
.3 mL volume) under 1, 50, or 80 bar hydrogen gas at 25, 50, 75, or
5
b
6) . Obtained (150 mg, 100% for Table 2, entry 24; 150 mg, 100%
ꢀ
Ò
1
00 C using H-Cube (ThalesNano Nanotechnology Inc.). Catalyst
cartridges were filled with 10% Pd/C (99.4 mg), 10% Pd/HP20
101.4 mg), 0.5% Pd/MS3A (99.6 mg), and 0.3% Pd/BN (99.7 mg). The
for Table 2, entry 26) from cinnamic acid benzyl ester (238 mg,
1
1
mmol). H NMR
d
(CDCl
3
) 2.69 (2H, t, J¼8.0 Hz), 2.98 (2H, t,
(
þ
J¼8.0 Hz), 7.21e7.33 (5H, m); MS (EI) m/z (%) 150 (M , 18), 104
reaction mixture was passed through the catalyst cartridge once
and MeOH (the carrier solvent) was concentrated in vacuo to give
an analytically pure product. The obtained product was identified
(100).
4
.3.10. 4-Ethylaniline (Table 2, entries 28 and 30).5b Obtained
1
by H NMR measurement.
(121 mg, 100% for Table 2, entry 28; 98 mg, 81% for Table 2, entry
1
3
3
0) from 4-ethynylaniline (117 mg, 1 mmol). H NMR d (CDCl ) 1.10
4
.3. Spectral data of products
(3H, t, J¼8.0), 2.45 (2H, q, J¼8.0), 3.42 (2H, br s), 6.51 (2H, d, J¼8.0),
þ
6
.89 (2H, d, J¼8.0); MS (EI) m/z (%) 121 (M , 35), 106 (100).
4
2
.3.1. Bibenzyl (Table 2, entries 1 and 2; Table 3, entries 1 and
). Obtained (182 mg, 100% for Table 2, entry 1; 182 mg, 100% for
5
b
4.3.11. N-Cbz-4-ethylaniline (Table 2, entry 29; Table 3, entry
5
b
Table 2, entry 2; 177 mg, 97% for Table 3, entry 1; 180 mg, 99% for
Table 3, entry 2) from diphenylacetylene (178 mg, 1 mmol). H NMR
d
21). Obtained (255 mg, 100% for Table 2, entry 29; 199 mg, 78%
1
1
for Table 3, entry 21) from 4-ethynylaniline (117 mg, 1 mmol). H
þ
(CDCl
3
) 2.93 (4H, s), 7.19e7.31 (10H, m); MS (EI) m/z (%) 182 (M ,
NMR
d
(CDCl
3
) 1.20 (3H, t, J¼7.6 Hz), 2.59 (2H, q, J¼7.6 Hz), 5.18 (2H,
21), 91 (100).
s), 6.68 (1H, br s), 7.1 (2H, d, J¼8.4 Hz), 7.24e7.40 (7H, m); MS (EI) m/
z (%) 147 (4-EtPheN]C]O, 100). Molecular ion peak was not lo-
cated in the mass spectrum.
4.3.2. 1, 2-Dimethoxy-4-propylbenzene (Table 2, entries 3 and 4;
5
b
Table 3, entries 3 and 4). Obtained (158 mg, 88% for Table 2, entry
; 151 mg, 84% for Table 2, entry 4; 164 mg, 91% for Table 3, entry 3;
60 mg, 89% for Table 3, entry 4) from 1,2-dimethoxy-4-
3
1
4.3.12. 1-Decylamine (Table 2, entries 31 and 33).15 Obtained
(157 mg, 100% for Table 2, entry 31; 155 mg, 99% for Table 2, entry
1
1
propenylbenzene (178 mg, 1 mmol). H NMR
d
(CDCl
3
) 0.93 (3H, t,
33) from N-(benzyloxycarbonyl)decylamine (291 mg, 1 mmol). H
J¼7.6 Hz), 1.59e1.65 (2H, m), 2.52 (2H, t, J¼7.8 Hz), 3.83 (3H, s), 3.85
NMR
d
(CDCl
3
) 0.88 (3H, t, J¼6.4 Hz), 1.27e1.32 (16H, m), 1.48 (2H,
þ
þ
(
3H, s), 6.70e6.78 (3H, m); MS (EI) m/z (%) 180 (M , 53), 151 (100).
s), 2.70 (2H, d, J¼7.2 Hz); MS (EI) m/z (%) 62 (M , 42), 31 (100).
4
.3.3. Ethyl 4-Aminobenzoate (Table 2, entries 5 and 6; Table 3, en-
4.3.13. Hydroquinone (Table 2, entries 34 and 35).16 Obtained
10
tries 5 and 6). Obtained (130 mg, 79% for Table 2, entry 5; 130 mg,
9% for Table 2, entry 6; 129 mg, 78% for Table 3, entry 5; 125 mg,
6% for Table 3, entry 6) from ethyl 4-azidobenzoate (191 mg,
(110 mg, 100% for Table 2, entry 34; 110 mg, 100% for Table 2, entry
1
7
7
1
4
35) from 4-(benzyloxy)phenol (200 mg, 1 mmol). H NMR
þ
d
(CD
3
OD) 6.61 (4H, s),; MS (EI) m/z (%) 108 [(Mꢁ2) , 100]. The MS
1
mmol). H NMR
d
(CDCl
3
) 1.37 (3H, t, J¼6.9 Hz), 4.05 (2H, br s),
spectrum of the product was identical with that of the authentic
sample obtained from commercial source (TCI), although molecular
ion peak was not located.
.33 (2H, q, J¼6.9 Hz), 6.65 (2H, d, J¼8.6 Hz), 7.87 (2H, d, J¼8.6 Hz);
þ
MS (EI) m/z (%) 165 (M , 42), 120 (100).
4
.3.4. Phenethylamine (Table 2, entries 8 and 10; Table 3, entries 16
4.3.14. Ethylene glycol (Table 2, entries 37 and 38).17 Obtained
11
and 18). Obtained (109 mg, 90% for Table 2, entry 8; 107 mg, 88% for
Table 2, entry 10; 104 mg, 86% for Table 3, entry 16; 108 mg, 89% for
Table 3, entry 18) from 2-phenylethylazide (147 mg,1 mmol). H NMR
(50.3 mg, 81% for Table 2, entry 37; 52.1 mg, 84% for Table 2, entry 38)
1
from 1,2-bis(benzyloxy)ethane (242 mg, 1 mmol). H NMR
d
3
(CDCl )
1
þ
2.01 (2H, br s), 3.74 (4H, s); MS (EI) m/z (%) 62 (M , 42), 31 (100).
d
(CDCl
3
) 1.31 (2H, br s), 2.75 (2H, t, J¼7.0 Hz), 2.97 (2H, t, J¼7.0 Hz),
þ
4.3.15. Phenethyl alcohol (Table 2, entries 39 and 40).18 Obtained
115 mg, 94% for Table 2, entry 39; 122 mg, 100% for Table 2, entry
40) from styrene oxide (31.8 mL, 1 mmol). H NMR d (CDCl ) 2.10
3
7
.19e7.22 (3H, m) 7.30 (2H, m); MS (EI) m/z (%) 121 (M ,12), 30 (100).
(
.3.5. 2, 6-Xylidine (Table 2, entries 12 and 14).12 Obtained
1
4
(
1
94.0 mg, 78% for Table 2, entry 12; 92.0 mg, 76% for Table 2, entry
4) from 2, 6-dimethylnitrobenzene (151 mg, 1 mmol). H NMR
(1H, s), 2.83 (2H, t, J¼6.8 Hz), 3.80 (2H, t, J¼6.8 Hz), 7.19e7.31 (5H,
1
þ
m); MS (EI) m/z (%) 122 (M , 11), 91 (100).
d
(CDCl
3
) 2.18 (6H, s), 3.56 (2H, br s), 6.63 (1H, t, J¼8.0 Hz), 6.94 (2H,
þ
d, J¼8.0 Hz); MS (EI) m/z (%) 121 (M , 100).
4.3.16. 2-Methyl-1,4-phenylenediamine (Table 3, entries
8
and
5
b
10). Obtained (93 mg, 76% for Table 3, entry 8; 110 mg, 90% for
4
.3.6. Anisalchol (Table 2, entries 16 and 18).13 Obtained (106 mg,
Table 3, entry 10) from 2-azido-5-nitrotoluene (178 mg,1 mmol). H
1
7
9% for Table 2, entry 16; 120 mg, 87% for Table 2, entry 18) from
NMR
d
(CDCl
3
) 2.12 (3H, s), 3.26 (4H, br s), 6.45e6.55 (3H, m); MS
1
þ
p-anisaldehyde (121
mL, 1 mmol). H NMR
d
(CDCl
3
) 3.78 (3H, s),
(EI) m/z (%) 122 (M , 100).
4
.58 (2H, s), 6.88 (2H, d, J¼8.8 Hz), 7.23 (2H d, J¼8.8 Hz); MS (EI) m/z
þ
(
%) 138 (M , 66), 77 (100).
4.3.17. 3-(4-Aminophenyl)propan-1-ol (Table 3, entries 11 and
19
1
2). Obtained (116 mg, 77% for Table 3, entry 11; 140 mg, 93% for
4
.3.7. Diphenylmethane (Table 2, entries 20 and 22).14 Obtained
Table 3, entry 12) from 4-nitrocinnamyl alcohol (179 mg, 1 mmol).
1
(
165 mg, 90% for Table 2, entry 20; 160 mg, 95% for Table 2, entry
H NMR
d
(CDCl
3
) 1.82 (2H, m), 2.57 (2H, t, J¼7.2), 2.93 (2H, br s),